Treatment of Chronic Alopecia Areata With Tildrakizumab: An Open-Label Pilot Study

    March 2020 in “ International Journal of Dermatology ”
    Karolina Louisa Suzanna Kerkemeyer, Rodney Sinclair
    Studysummary This correspondence about the treatment of chronic alopecia areata with tildrakizumab reports no clinical results; the authors present an open-label pilot study setup.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on minerva-access.unimelb.edu.au →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Cyclosporine for Moderate-to-Severe Alopecia Areata: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety Journal of the American Academy of Dermatology · 2019
    2. Treatment of Alopecia Areata: An Australian Expert Consensus Statement Australasian journal of dermatology · 2018
    3. Systemic Treatments for Alopecia Areata: A Systematic Review Australasian journal of dermatology · 2018

    Related research 1

    1. Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child International journal of research in dermatology · 2019